Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 15, 2021 - Issue 8: COVID-19
Submit an article Journal homepage
400
Views
14
CrossRef citations to date
0
Altmetric
Meta-analysis

Does methylprednisolone reduce the mortality risk in hospitalized COVID-19 patients? A meta-analysis of randomized control trials

Syed Shahzad Hasana Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4058-2215View further author information
ORCID Icon,
Chia Siang Kowb School of Postgraduate Studies, International Medical University, Kuala Lumpur, MalaysiaORCID Iconhttps://orcid.org/0000-0002-8186-2926View further author information
ORCID Icon,
Zia Ul Mustafac Department of Pharmacy, District Headquarters Hospital, Pakpattan, PakistanORCID Iconhttps://orcid.org/0000-0002-8109-4859View further author information
ORCID Icon &
Hamid A. Merchanta Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, UKORCID Iconhttps://orcid.org/0000-0002-7668-5013View further author information
ORCID Icon
Pages 1049-1055 | Received 02 Mar 2021, Accepted 30 Apr 2021, Published online: 02 Jul 2021

References

  • Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395(10223):473–475.
  • Hasan SS, Capstick T, Ahmed R, et al. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med. 2020;14(11):1149–1163.
  • RECOVERY Collaborative Group, Horby P, Ws L, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384(8):693–704.
  • WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne JAC, Murthy S, et al. Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19: a meta-analysis. JAMA. 2020;324(13):1330–1341.
  • Ko JJ, Wu C, Mehta N, Wald-Dickler N, Yang W, Qiao R. Comparison of Methylprednisolone and Dexamethasone in intensive care patients with COVID-19 [published online ahead of print, 2021 Feb 25]. J Intensive Care Med. 2021;885066621994057. DOI:10.1177/0885066621994057
  • Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
  • Kiser TH, Allen RR, Valuck RJ, et al. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):1052–1064.
  • Tang X, Feng YM, Ni JX, et al. Early use of corticosteroid may prolong SARS-CoV-2 shedding in non-intensive care unit patients with COVID-19 Pneumonia: a Multicenter, single-blind, randomized control trial. Respiration. 2021;100(2):116–126.
  • Jeronimo CMP, Farias MEL, Val FFA, et al. Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19 (Metcovid): a randomised, double-blind, phase IIb, placebo-controlled trial. Clin Infect Dis. 2021;72(9):e373–e381.
  • Corral-Gudino L, Bahamonde A, Arnaiz-Revillas F, et al. Methylprednisolone in adults hospitalized with COVID-19 pneumonia: an open-label randomized trial (GLUCOCOVID). Wien Klin Wochenschr. 2021;133(7-8): 303–311.
  • Edalatifard M, Akhtari M, Salehi M, et al. Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial. Eur Respir J. 2020;56(6):2002808.
  • Kow CS, Hasan SS. Corticosteroid-related in-hospital hyperglycemia: does it negate mortality benefits in COVID-19? [published online ahead of print, 2020 Sep 18]. Clin Infect Dis. 2020;ciaa1423. DOI: 10.1093/cid/ciaa1423
  • Pasricha JS. Pulse therapy as a cure for autoimmune diseases. Indian J Dermatol Venereol Leprol. 2003;69(5):323–328.
  • Ranjbar K, Moghadami M, Mirahmadizadeh A, et al. Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial. BMC Infect Dis. 2021;21(1):337.
  • Ayyar VS, Song D, DuBois DC, et al. Modeling corticosteroid pharmacokinetics and pharmacodynamics, Part I: Determination and prediction of dexamethasone and methylprednisolone tissue binding in the rats. J Pharmacol Exp Ther. 2019;370(2):318‐326.
  • ClinicalTrials.gov. Timing of Corticosteroids in COVID-19. [cited 2021 April 12]. https://clinicaltrials.gov/ct2/show/NCT04530409
  • Bahl A, Johnson S, Chen NW. Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients [published online ahead of print, 2021 Feb 5]. Intern Emerg Med. 2021;1-11. DOI: 10.1007/s11739-021-02655-6
  • Lee N, Allen Chan KC, Hui DS, et al. Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. J Clin Virol. 2004;31(4):304–309.
  • ClinicalTrials.gov. Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT) (MEDEAS). [cited 2021 April 12]. https://clinicaltrials.gov/ct2/show/NCT04636671
  • Methylprednisolone. British National Formulary, National Institute for Health and Clinical Excellence (NICE). [cited 2021 April 11]. https://bnf.nice.org.uk/drug/methylprednisolone.html
  • Spoelhof B, Ray SD. Corticosteroids, Editor(s): Philip Wexler, encyclopedia of toxicology. Third. Academic Press (London); 2014. 1038–1042. DOI:10.1016/B978-0-12-386454-3.00293-1.
  • Dexamethasone 3.3 mg/ml solution for injection, summary of product characteristics from Hospira UK Limited, eMedicine Compendium. [cited 2021 April 10]. https://www.medicines.org.uk/emc/product/570/smpc
  • Solu-Medrone 1 gram powder for injection, summary of product characteristics, Pfizer Limited, eMedicine Compendium. [cited 2021 April 10]. https://www.medicines.org.uk/emc/product/3066/smpc

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.